semaglutide obstructive sleep apnea trial Randomised, cOntrolled Multicentre of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and Diabetes & Weight Loss Drug

The researchers on the new analysis noted that, in addition to some differences in the people who enrolled in each trial, the previous study was designed specifically for weight loss and included more structured lifestyle interventions about diet and exercise compared with the Select trial, which was designed to test whether the drug prevented cardiac events

The Capybara home screen widget shows where you are on protein, water, fiber, and steps without opening the app which matters most on the days you would otherwise skip a glass of water or under-eat protein and not notice until the week feels rougher than expected

Things are moving especially fast, and pill versions of GLP-1 drugs are now on the market

Sep 2022;14(9):e29480

Research questions include whether GLP-3 affects body composition differently than GLP-1, potentially preserving more muscle mass during weight loss, if GLP-3 enhances fat oxidation and metabolic rate through distinct pathways, whether combining GLP-3 with GLP-1 approaches offers advantages over either alone, and how GLP-3 might benefit metabolic flexibility and long-term weight maintenance

There are relatively high levels of obesity in various Asian markets, averaging at an overall 20% or so, NielsenIQ Regional Executive Director Craig Houliston told us